Substance-induced respiratory depression Respiratory
Conditions
Interventions
PneumoWave DC chest biosensor is a small cylindrical device (40 mm diameter 14mm height) that sticks onto the chest using a small plastic patch (an ECG sticker) and measures chest motion. The study wi
Sponsors
University of Dundee
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Over 18 years of age 2. Living in supported accommodation 3. Participant reported current opiate drug use 4. Willing to wear biosensor device while living in supported accommodation 5. Able to provide informed consent (not intoxicated at time of consent) 6. Able to converse in and understand English
Exclusion criteria
Exclusion criteria: 1. Does not meet one or more of the inclusion criteria 2. Skin sensitivity to ECG electrode patch 3. Broken skin over chest area 4. Implanted pacemaker device in-situ 5. Not suitable for enrolment in the opinion of site staff or investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evidence of reduced chest movement collected by the PW DC system captured as a waveform throughout the duration of the study | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. User and staff experience and acceptability captured via responses to a questionnaire completed at least once during the study and via an interview and/or focus group participation at the end of the study 2. Potential causes for substance-induced respiratory depression captured via a drug use diary completed by the participant throughout the study | — |
Countries
England, Scotland, United Kingdom
Contacts
Public ContactCatriona ;Sarch Cowan;Inglis
;
Outcome results
None listed